Advancing Standards, Strengthening Safety, and Building Forward Momentum
As we move beyond the first quarter of the year, it is an appropriate moment to reflect not only on where we began, but on the measurable progress we have made as a Society. The early months of this presidency were defined by urgency; an inflection point that demanded clarity of purpose, decisive leadership, and a recommitment to the foundational principles of safety, scientific rigor, and professional integrity in hyperbaric medicine.
What has followed is not simply continuation, but acceleration.
From a governance standpoint, the Society has strengthened its internal alignment. Committee activity has been re-energized with clearer mandates, improved communication pathways, and renewed expectations for deliverables that translate directly into operational and clinical impact. This is not theoretical work but rather structured, accountable, and increasingly visible across all UHMS domains.
A central pillar of this quarter and the past year has been safety reform. In the wake of recent fatalities associated with non-accredited hyperbaric operations, the Society has taken a firm and unequivocal position. We have made significant progress in eliminating the use of chambers that do not meet ASME-PVH standards. This has required coordinated engagement across multiple fronts: policy articulation, external communication, and collaboration with regulatory and accreditation bodies. The message is clear: hyperbaric oxygen treatment must be delivered within systems that meet established engineering and safety benchmarks. Anything less is unacceptable.
This initiative is not merely reactive. It is proactive standard-setting. We are working toward a landscape in which facility accreditation is not optional or aspirational but expected and enforced. The long-term objective is a unified safety framework that protects patients, providers, and the credibility of the field itself.
In parallel, we have continued to advance the Society's scientific and educational mission. Preparations for the upcoming Annual Scientific Meeting are well underway, and this year’s meeting represents a meaningful evolution. Our collaboration with the Aerospace Medical Association brings together two disciplines that share physiological foundations and operational challenges. The integration of these communities is expected to elevate the scientific discourse, broaden interdisciplinary engagement, and reinforce the UHMS as a central authority in pressure-related medicine.
The selection of Denver as the host city is fitting. It provides not only a geographic nexus but also a symbolic one, bridging altitude physiology, aerospace medicine, and hyperbaric science. The program is being designed with intention: high-yield scientific sessions, operationally relevant safety discussions, and forward-looking panels that address emerging indications and technologies. This will not be a passive meeting; it will be an active forum for shaping the next phase of our specialty.
Beyond meetings and policy, there has been continued progress in standardization efforts. Terminology, clinical frameworks, and educational materials are being refined to reflect a more precise and disciplined approach to our field. Language matters. It defines how we are perceived, how we train, and how we practice. Aligning around accurate terminology, such as the consistent use of “hyperbaric oxygen treatment”, is part of a broader effort to reinforce professionalism and clinical identity.
Importantly, the Society has also begun to reassert its role externally. Whether through engagement with hospital systems, academic institutions, or industry partners, there is a renewed presence and authority. We are not observers of the evolution of hyperbaric medicine; we are shaping it.
There is, however, no room for complacency. The work ahead remains substantial. Accreditation gaps persist. Variability in clinical practice continues. Emerging indications require disciplined evaluation. And the need for strong physician leadership in hyperbaric programs has never been more evident. What has changed is our posture. We are moving with intent.
The first quarter established the tone. The months since have demonstrated execution. As we look ahead, the focus remains clear: elevate standards, enforce safety, expand scientific contributions, and ensure that hyperbaric oxygen treatment is delivered with the rigor our patients and our profession demand. This is the trajectory of the Society. And we will continue to drive it forward.
At the upcoming Annual Scientific Meeting in May, I will conclude my term as president of the Society. I will move on to my new role as the immediate past president and pass the gavel to Sandra Wainwright. It has been a privilege to serve in this role during a period that demanded both urgency and resolve. I have the utmost confidence in Sandra’s leadership and her ability to carry this Society forward by continuing to elevate standards, strengthen safety, and advance the scientific and clinical mission of hyperbaric medicine. Our trajectory is clear, and it is in very capable hands.